Vivione Biosciences Inc. announced that it has received $1 million in funding from Montalcino Holdings I, LLC

Vivione Biosciences Inc. is a technology and life sciences company. The Company is focused on rapid bacterial detection. The Company has developed a diagnostic system called RAPID-B, which tests bacteria in critical environments and provides quantitative results in approximately seven hours or less. Its RAPID-B is an integrated microbiology/infectious disease diagnostic system. Its primary targeting is accomplished with custom, optimized immuno-based reagents that are designed to target the cell surface of target bacteria without cross-reactivity to similar non-target bacteria. Its RAPID-B system has applications in various markets, including Hospitals, Universities and Clinics; testing system for bacterial detection and antimicrobial susceptibility profiles for bacterial infection in normally sterile body fluids, such as blood and urine, and detecting the presence of bacteria in blood and urine samples within minute's and days.